To understand whether CD147 and MCT4 are potential targets for the SARS-CoV-2 spike protein binding to megakaryocytic cells, we used a SARS-CoV-2 pseudovirus to perform a series of infection of Dami and PMA-Dami cells, treated with AC-73 (10 μM) or SYRO (2.5 μM), as compared to untreated cells. Here, BSG is linked to infection.